Early this month, in a bold step to safeguard the health and future of our children, the Ministry of Health launched one of its most zealous health campaigns yet, aiming to immunise over 20 million children in Kenya against life-threatening diseases like tetanus, polio, Rubella and measles.
This campaign—launched in collaboration with global health partners such as WHO, Unicef, PATH and Gavi— is a significant step toward universal child immunisation and a massive communication undertaking. The campaign reached many zero-dose children (those who had never received routine immunisation).
Kenya's media was critical in amplifying public health messaging, building public trust, and mobilising communities. The media did a virtuous job.
Still and all, our media ecosystems should gradually start reframing narratives depicting the steady growth and development of Kenya and Africa's geopolitical positioning on equitable healthcare access, focusing more on the emergence of local vaccine manufacturers.
We should moderately shift from stories of foreign charity to stories of leadership, resilience, and innovation.
To achieve this, the media can do more in prioritising humanising the vaccine production landscape by profiling outstanding Kenyan and African scientists, the technicians ensuring quality control, regulators upholding safety standards, and health officials leading national immunisation programmes. These stories foster a sense of pride, trust, and relatability.
The public is more likely to connect emotionally with the process by giving a face to the effort, reducing skepticism and encouraging community buy-in for the coming locally produced vaccines.
We also have a long way to go regarding unpacking scientific jargon. Scientific processes — such as the development of vaccines — can feel opaque or out of reach for many people and are easy pickings for doubt and fear. The media is vital in translating complex science into digestible, culturally relevant stories.
Lastly, it is uncontested that the media plays a defining role in shaping how Kenya and Africa's vaccine journey is perceived, understood, and supported—domestically and globally.
So far, our media has been doing a commendable job on health reporting, but can do more to reconstruct the dominant narrative of vaccine dependence by spotlighting local success stories, such as African-led vaccine and biotherapeutics research breakthroughs, government investments in health infrastructure, and the emergence of homegrown vaccine manufacturers.
The writer is the Head of Corporate Communication Division at Kenya BioVax Institute
Unlock a world of exclusive content today!Unlock a world of exclusive content today!
